Cornea/External Disease News

MONTEREY, Calif. — In this Healio Video Perspective from the Women in Ophthalmology Summer Symposium, Jennifer M. Loh, MD, discusses how cases of Demodex blepharitis can sometimes masquerade as severe dry eye disease.

LAS VEGAS — Théa Pharma Inc. showcased AcellFX, an acellular amniotic membrane the company acquired from Akorn earlier this year, as well as its iVizia line of dry eye products, at Vision Expo West.

Sight Sciences has completed enrollment in the SAHARA trial, which is evaluating the TearCare system to treat the signs and symptoms of dry eye disease, according to a press release.

MONTEREY, Calif. — In this Healio Video Perspective from the Women in Ophthalmology Summer Symposium, Jennifer M. Loh, MD, discusses meibomian gland dysfunction in patients 1 month after TearCare treatment.

Johnson & Johnson Vision introduced Acuvue Oasys Max 1-Day, new daily disposable premium contact lenses available in spherical and multifocal designs.

Human coronavirus was easily removed from soft and gas-permeable contact lens materials when rubbed or rinsed with only saline, according to a new study in Contact Lens and Anterior Eye.

MONTEREY, Calif. — OC-01 nasal spray showed a significant decrease in the signs and symptoms of dry eye in patients with autoimmune disease and associated dry eye disease.

AR-15512, a transient receptor potential melastatin 8 agonist, demonstrated significant improvement of dry eye disease signs, symptoms and related quality of life in a phase 2b study.

Blinkcns Inc. and the Zucker Institute for Innovation Commercialization at the Medical University of South Carolina have announced a licensing agreement to advance blink reflex technology and software EyeStat.

As an eye care provider, I know it can be frustrating to identify an ocular abnormality without a readily available treatment.